Leadless Pacemakers: Current and Future Applications
Journal Title: Advancements in Cardiovascular Research - Year 2018, Vol 1, Issue 4
Abstract
Since its first prototype proposed in the 1970s [1], pacing technology has progressively developed sophisticated miniaturization of electronic component of device, abolished the need for leads, and greatly improved battery longevity in order to provide greater autonomy. Finally, in 2012, leadless pacemakers became a commercially available alternative to traditional transvenous/epicardial pacing first with the introduction of Nanostim (St. Jude Medical Inc.; now Abbott Medical Inc., Abbott Park, IL, USA) and shortly after with the Micra leadless pacemaker (Medtronic Plc, Minneapolis, MN, USA). The main advantage of leadless pacing technology over traditional pacing technology should essentially be to avoid lead- and pocket-related complications. The incidence of post implant complications has been estimated as high as 10% [2] and it accounts for short term complications (such as pneumothorax, cardiac tamponade, pocket hematoma and lead dislodgement) and long term complications, mostly due to the vulnerable component of the system, the transvenous leads (such as insulation breaches and lead fractures), but also skin erosions, pocket or systemic infections, venous obstruction, tricuspid regurgitation and endocarditis
Authors and Affiliations
E Zimelli, G Morani
Keywords
Related Articles
- EP ID EP586976
- DOI 10.32474/ACR.2018.01.000119
- Views 59
- Downloads 0
Problems of Biomineralization Dissolution in Human Arteries
Plenty has been written about the impact of arteriosclerosis, i.e. arterial biomineralization, on the functioning of human body. A little less information is available concerning the dissolution and prevention of such mi...
Neuroleptic Cardiomyopathy and Myocardial Hibernation
Aim: It is to summarize and in a new way to interpret the data, which have been earlier received, in order to prove the development of the hibernation of myocardium (HM) in cases of the neuroleptic cardiomyopathy (NCMP)....
Retrograde Recanalization of Chronic Coronary Occlusions
Chronic coronary occlusion (SRT) is recorded in 1 of 5 patients who underwent cardiac catheterization. Interventional interventions in patients with IHD with chronic coronary occlusions are amo...
Sleep Quality Disturbances and Blood Pressure Values
The aim of the study was to find out whether early blood pressure (TK) values in patients with fixed and medically treated hypertension correlated with sleep quality during the previous night, and that treatment with ril...
Cardiac Remodeling During the Morphogenesis of Neuroleptic Cardiomyopathy
Introduction: A neuroleptic cardiomyopathy NCMP belongs to secondary specific metabolic dilated cardiomyopathies. It is caused by side cardiotoxic effect of antipsychotic preparations. In its development NCMP passes thre...